PharVision Advisers’s ContextLogic LOGC Stock Holding History

PharVision Advisers’s Portfolio LOGC Stock Details LOGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-26,330	Closed	-$185K	–	544
2024 Q4	$185K	Buy	+26,330	New	+$175K	0.16%	322

Other funds holding LOGC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return

BOA

Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return

ACA

AYAL Capital Advisors Toronto, Ontario, Canada $369M AUM 39.67% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PharVision Advisers's LOGC Position: Q1 2025 in Review

PharVision Advisers sold out of ContextLogic (LOGC) in Q1 2025, closing a stake of 26,330 shares — an estimated $185K sold.

PharVision Advisers first reported a position in LOGC in Q4 2024 and held it in 1 quarter. The position peaked at $185K in Q4 2024. 92 funds tracked by Wall St. Rank hold LOGC as of Q1 2025.

PharVision Advisers reported no remaining ContextLogic position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 26,330 ContextLogic shares in Q1 2025, an estimated $185K.
PharVision Advisers first reported a position in ContextLogic in Q4 2024 and held it in 1 quarter.
PharVision Advisers's ContextLogic position peaked at $185K in Q4 2024.
92 funds tracked by Wall St. Rank held ContextLogic as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.